Futura Medical (LON:FUM) Trading Down 5.5% – Should You Sell?

Shares of Futura Medical plc (LON:FUM) were down 5.5% during trading on Thursday . The company traded as low as GBX 0.64 and last traded at GBX 0.73. Approximately 1,248,722 shares changed hands during trading, a decline of 80% from the average daily volume of 6,124,176 shares. The stock had previously closed at GBX 0.77.

Futura Medical Stock Performance

The firm has a market cap of £3.95 million, a P/E ratio of -0.24 and a beta of 0.01. The stock’s 50 day simple moving average is GBX 0.96 and its 200 day simple moving average is GBX 1.13.

Futura Medical (LON:FUM) last announced its earnings results on Wednesday, April 29th. The company reported GBX (2.78) earnings per share (EPS) for the quarter. The company had revenue of GBX 170 million for the quarter. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%. As a group, analysts forecast that Futura Medical plc will post 2.8486672 EPS for the current fiscal year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.